Human Metapneumovirus (HMPV) is becoming a significant pathogen of attention in China, where respiratory disorders are on the rise. According to reports, influenza A, Mycoplasma pneumoniae, COVID-19, and HMPV are among the respiratory illnesses that are now on the rise, especially in the northern regions. An increase in HMPV in China instances among children under the age of 14 was noted in a Reuters investigation.

China’s disease control authorities have implemented a surveillance system for pneumonia of unknown origin in response to this, anticipating a seasonal surge in the disease throughout the winter and spring. Social media has suggested an emergency declaration and overloaded hospitals, but no official confirmation of these actions has been made.

Comparing HMPV and Covid-19

Despite being members of distinct viral families, HMPV and SARS-CoV-2, the virus that causes COVID-19, have several similarities. Both attack the respiratory system and spread via contaminated surfaces and respiratory droplets. Both viruses can cause symptoms, including fever, coughing, sore throat, wheezing, and dyspnea.

Children, the elderly, and people with impaired immune systems are among the categories most susceptible to both viruses. Both require preventative strategies such as mask-wearing, hand washing, and social distancing. The fact that there is presently no vaccine or readily accessible antiviral therapy for HMPV, although there are options for COVID-19, such as Paxlovid, is a notable distinction.

Also Read: UK’s Largest Dinosaur Footprint Trackway Discovered In Oxfordshire Quarry

Trends and Expert Opinions

Following the COVID-19 pandemic, HMPV in China became a growing concern, with Henan, China, experiencing a spike in HMPV infections, according to research published in the Virology Journal in April 2024. The virus’s influence on public health was further highlighted by the fact that it commonly resulted in hospital admissions between April and June 2023.

Since respiratory illnesses are predicted to increase throughout the winter, experts stress the importance of monitoring and public health initiatives. To control the virus’s spread and public anxiety, open communication and readiness are crucial.

However, no HMPV cases were confirmed by the National Centre for Disease Control (NCDC) in India. HMPV is similar to ordinary cold viruses, and its symptoms may be controlled with normal cold or fever drugs, said NCDC head Dr. Atul Goyal. He stressed that there is no immediate need for concern and that hospitals are prepared to manage any possible surges.

Also Read: India Achieved 36% Reduction In Emission Intensity Of GDP By 2020 Compared To 2005 Levels